Cidara Therapeutics (NASDAQ:CDTX) Price Target Raised to $50.00 at Guggenheim
Cidara Therapeutics (NASDAQ:CDTX – Free Report) had its price objective boosted by Guggenheim from $35.00 to $50.00 in a research report released on Friday morning,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. Several other equities research analysts also recently commented on CDTX. Cantor Fitzgerald upgraded Cidara Therapeutics to a “strong-buy” […]
Cidara Therapeutics (NASDAQ:CDTX – Free Report) had its price objective boosted by Guggenheim from $35.00 to $50.00 in a research report released on Friday morning,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. Several other equities research analysts also recently commented on CDTX. Cantor Fitzgerald upgraded Cidara Therapeutics to a “strong-buy” […]
